A bill to improve transparency with respect to foreign influence on Department of Defense contractors.
Sponsor

Full profile: /officials/W000817
Source: Congress.gov · FEC
Cosponsors (1)
Members who have signed on to support this bill since introduction. Source: Congress.gov.
Latest Action
The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →
Committee Activity
Currently in
- Senate Committee on Armed ServicesReferred To · 2026-06-01
Plain-English Summary
The bill would require Department of Defense contractors to disclose their foreign ownership, investments, and business relationships to increase transparency about potential foreign influence on military suppliers. This would help the Pentagon and Congress better understand which defense companies have significant foreign connections that could affect national security. The measure affects defense contractors and their foreign investors or business partners.
AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.
Full Bill Text
Verbatim text published on Congress.gov via GovInfo. Use Cmd+F / Ctrl+F to search within this excerpt.
[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [S. 4648 Introduced in Senate (IS)] <DOC> 119th CONGRESS 2d Session S. 4648 To improve transparency with respect to foreign influence on Department of Defense contractors. _______________________________________________________________________ IN THE SENATE OF THE UNITED STATES June 1, 2026 Ms. Warren (for herself and Mr. Grassley) introduced the following bill; which was read twice and referred to the Committee on Armed Services _______________________________________________________________________ A BILL To improve transparency with respect to foreign influence on Department of Defense contractors. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. IMPROVING TRANSPARENCY OF FOREIGN INFLUENCE ON DEPARTMENT OF DEFENSE CONTRACTORS. (a) Defense Contractors and Subcontractors Generally.--Not later than 2 years after the date of the enactment of this Act, the Secretary of Defense shall revise the Defense Federal Acquisition Regulation Supplement to require any company that is a prospective contractor or subcontractor of the Department of Defense to provide to the Federal Government as part of any bid or proposal for a contract the information specified under subsection (a) of section 2876 of the National Defense Authorization Act for Fiscal Year 2018 (10 U.S.C. 2661 note) for each beneficial owner (as that term is defined in subsection (d)(1) of such section) of such company. (b) Mitigation of Risks Related to Foreign Ownership, Control, or Influence of Defense Industrial Base Contractors and Subcontractors.-- Section 847(a) of the National Defense Authorization Act for Fiscal Year 2020 (Public Law 116-92; 10 U.S.C. 4819 note) is amended-- (1) in paragraph (1), by inserting ``, and shall include any person defined as a `beneficial owner' under section 2876(d)(1) of the National Defense Authorization Act for Fiscal Year 2018 (10 U.S.C. 2661 note)'' before the period at the end; and (2) in paragraph (3), by striking ``in excess of $5,000,000'' and inserting ``in excess of $500,000''. <all>
Related legislation
Bills by the same sponsor or covering overlapping subjects.
- S4684A bill to amend the Consumer Financial Protection Act of 2010 to set a compulsory funding floor for the Bureau of Consumer Financial Protection, and for other purposes.Referred to Committee · 2026-06-04
- S4550Maternal Health Pandemic Response ActReferred to Committee · 2026-05-18
- SRES732A resolution expressing the sense of the Senate that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.Referred to Committee · 2026-05-14
- S4509PBM ActReferred to Committee · 2026-05-13